<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">Symptoms of COVID-19 are non-specific range from no symptom to severe pneumonia and death. Different studies have reported different symptoms, including fever, cough, fatigue or myalgia and atypical symptoms include hemoptysis, diarrhea, headache and sputum. Other symptoms include lymphocytopenia and all patients had pneumonia (
 <xref rid="b0185" ref-type="bibr">Huang et al., 2020</xref>). Various studies have reported different fatality rates in different age groups. In one research it is presented that patients greater than 60 are at higher risk than younger one (
 <xref rid="b0200" ref-type="bibr">Jordan et al., 2020</xref>). In another report, it is investigated that patients of age group 30–79 years appeared to more vulnerable to COVID-19 (
 <xref rid="b9000" ref-type="bibr">Wu et al., 2020</xref>). The complete sequence of SARS-2 has been obtained and disease can be diagnosed by RT- PCR and sample is collected from both lower or upper respiratory tract or by counting the total number of leucocyte and lymphocytes (
 <xref rid="b0090" ref-type="bibr">Corman et al., 2020</xref>
 <italic>:</italic>
 <xref rid="b0195" ref-type="bibr">Jin et al., 2020</xref>). In China, it is reported in a preliminary study that SARS-CoV-2 has gained a number of mutations. The high mutation rate of coronavirus can cause problems for process of vaccine development. It is investigated that intense quarantine and social distancing measures are helpful in controlling the outbreak. Some of the allopathic medicines (Chloroquine, Lopinover, Oseltamivir and Retenover etc.) used for other purposes like malaria have proved effective for corona but their efficacy is not yet established. In China, traditional herbal treatment was also adopted against COVID-19 and has shown good results. Herbal decoctions were suggested by the National Health Commission of China. (
 <xref rid="b0230" ref-type="bibr">Luo et al., 2020</xref>, 
 <xref rid="b0180" ref-type="bibr">Ho et al., 2020</xref>).
</p>
